Arca
Skip to content
Tools
Tools

Stomatitis

Drug research and approvals for stomatitis: what is recruiting, what Health Canada authorized, FDA orphan designations and EU medicines. See every condition.

As of Nov 21, 2026, 51 studies of stomatitis are recruiting on ClinicalTrials.gov, Health Canada has authorized 0 drug trials for it since 2013, and FDA has 0 approved and 3 open orphan designations naming it.

  • Recruiting worldwide: 51
  • Trials authorized in Canada: 0
  • FDA orphan approvals: 0
  • EU medicines: 0

Recruiting now

Newest posted first, of 51 recruiting on ClinicalTrials.gov ↗

Drug pipeline

Each drug at the furthest stage it has reached for this condition, from ChEMBL's drug indications

Approved 1

  • PaliferminFibroblast growth factor receptor 2 agonist

Phase 3 12 of 16

Phase 2 12 of 25

Phase 1 or earlier 3

How its trials ended

354 ClinicalTrials.gov studies of the condition, classified by TrialPanorama, partly automatically, so some labels are wrong

Of the 58 whose ending is known, 33% met their primary endpoint, 7% missed it and 60% stopped early.

  • Completed, result not reported16747%
  • Ongoing6619%
  • Status unknown6318%
  • Met its primary endpoint195%
  • Stopped: other or unclear165%
  • Stopped: enrollment or feasibility82%
  • Missed its primary endpoint41%
  • Stopped: sponsor or business decision41%
  • Stopped: lack of efficacy31%
  • Stopped: funding31%
  • Stopped: safety1<1%

FDA orphan designations

Approved first, then open designations, newest first
Jun 29, 1999Lactic acidTreatment of severe aphthous stomatitis in severely, terminally immunocompromised patients.Frontier Pharmaceutical, Inc.Designated
May 1, 1995ThalidomideTreatment of severe recurrent aphthous stomatitis in severely, terminally immunocompromised patients.Celgene CorporationDesignated
Jul 15, 1993SucralfateTreatment of oral mucositis and stomatitis following radiation therapy for head and neck cancer.Fuisz Technologies, Ltd.Designated

Condition names come from Health Canada's trial database. Orphan designations and EU medicines are matched when their indication names the condition as whole words, so a broader or differently worded indication can be missed. Recruiting counts are live from ClinicalTrials.gov's own condition search, refreshed daily. ClinicalTrials.gov, Health Canada Clinical Trials Database, FDA orphan designations, EMA

Esc

Type a name: a tool, a company, a drug or brand, a condition, a gene or a state. Identifiers like K231234, NCT05012345 or NDA 215866 open their record.

Logos are each company's own site icon, matched by name through Wikidata, or logos provided by Logo.dev.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.